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Abstract 36 
Lineage tracing strategies is proving to be a powerful approach for tracking cells in vivo, and is transforming 37 
our understanding of the cell fate changes that underlie kidney pathophysiology. The technologicaladvances 38 
in lineage tracing approaches is permitting novel spatial, temporal and kinetic resolutions into mechanisms 39 
responsible for tissue renewal and repair. In particular, lineage tracing has been used to investigate the 40 
possible role of stem/progenitor cells in kidney development, homeostasis and regeneration. Recently, the 41 
production of novel murine models where individual cells are tagged, assist in clarification of mechanisms of 42 
kidney regeneration and new answers to old questions are gradually being unraveled. The complexity of 43 
these genetically engineered systems requires careful analysis and interpretation. Caution must be paid 44 
particularly on the type of promoter, switch and reporter used, as well as on the induction times that are best 45 
to study the pre-specified end points.Here, we focus on the main points that need to be considered to 46 
interpret results obtained with lineage tracing, as well as on novel techniques that are becoming available, 47 
with a particular emphasis on their use for studying putative renal progenitors and the mechanisms of kidney 48 
regeneration. 49 
Keypoints 50 
 The principle of lineage tracing is based on marking a single cell in such a way that the mark is 51 
transmitted to the cell's progeny. 52 
 Lineage tracing can provide information about the number of progeny of the founder cell, their 53 
location, and their differentiation status. 54 
 The critical points to consider for an appropriate evaluation of the data obtained with lineage tracing 55 
should be three: the promoter, the switch and the reporter. 56 
 The choice of the promoter should be optimized based on the cell type that has to be studied.  57 
 The best possible promoter is one that is specifically and selectively expressed by the cell type 58 
analysed.  59 
 For any kind of promoter system used, the expression pattern has to be verified prior to the actual 60 
cell fate tracing experiments. 61 
 If the cell type marked by the promoter is unknown, negative results never allow definitive 62 
conclusions. 63 
 The switch is usually a drug-regulated form of the bacterial enzyme Cre recombinase, which 64 
activates the transgene to allow turning on and off transcription of the reporter in a time-dependent 65 
manner.  66 
 The use of lines that express Creconstitutively is problematic for lineage tracing, because transient or 67 
later expression of the gene in other cellsalso likely inducesde novo activation of Crerecombinase, 68 
potentially altering results interpretation. 69 
 Critical points to evaluate the results are also represented by the induction times used to study the 70 
pre-specified end points. 71 
 Fluorescent reporters allow not only qualitative evaluation of phenomena but also quantitation and 72 
live imaging through dual or multiphoton microscopy. 73 
 Use of multicolor reporters allows evaluation of cell division and clonal analysis and provides the 74 
most accurate genealogical descriptions of stem/progenitor behaviors. 75 
 76 
  77 
Until recently, the behavior of cells in vivo could only be inferred indirectly, and consequently the basis of 78 
tissue biology in the kidney was ill-defined. However, lineage tracing in transgenic mice is proving to be a 79 
powerful approach for tracking cell fate in vivo, and it is transforming our understanding of the cell fate 80 
changes that contribute to kidney injury and regeneration. Traditionally used in developmental biology, 81 
lineage tracing has become an essential tool also in stem cell research, because it provides information about 82 
how the cell behaves in the context of the intact tissue or organism.1-6 Tracking cells in their native habitat 83 
has provided insight into how the balance of proliferation and differentiation is achieved to an extent never 84 
before envisaged and thus, lineage tracing is increasingly applied to solve numerous scientific problems. In 85 
particular, the use of lineage tracing has provided unprecedented levels of information about clonal dynamics 86 
and the organization of the stem cell compartment in postnatal tissues2-7 and has recently been used to 87 
investigate the possible role of resident progenitor/stem cells in kidney development, homeostasis and 88 
regeneration.8-12However, the inherent complexity of genetic recombination techniques and the increasing 89 
number of possibilities associated with this technology makes the interpretation of the results of these studies 90 
accessible only to experts. Several excellent reviews were focused on the technical aspects of lineage 91 
tracing.13-15In this Review, we focus on the main points that need to be considered to interpret results 92 
obtained with lineage tracing, with a particular emphasis on their use for studying putative renal progenitors 93 
and the mechanisms of kidney regeneration. 94 
 95 
Lineage tracing: how it works The basic concept of lineage tracing is simple, and is based on marking a 96 
single cell in such a way that the mark is transmitted to the cell's progeny. To this aim, expression of a 97 
reporter gene, such as the enzyme β-galactosidase or a fluorescent protein, is switched on in a subset of cells 98 
in a tissue16,17. If the labelled cells divide, they pass on the expression of the reporter to their daughter cells, 99 
and form clusters of labelled cells, providing information about the number of progeny of the founder cell, 100 
their location, and their differentiation status. 101 
To conduct a lineage-tracing experiment a switch that is usually a drug-regulated form of the bacterial 102 
enzyme Cre recombinase, must be engineered into the mouse genome. This enzyme recognizes specific 103 
sequences, called LoxP sites16,17, that are not naturally found in the mouse genome, and are inserted only in 104 
transgenic constructs used to create the transgenic line (Fig.1). Put simply, Crerecombinase excises the DNA 105 
between LoxP sites and rejoins the ends16(Fig.1). To control Cre activity have been developed modified 106 
promoters that are active only in specific cell populations and allow Cre transcription exclusively in a drug-107 
sensitive fashion, thus leading to reporter expression.13-17Already from this summary, it is clear that the 108 
critical points to consider for an appropriate evaluation of the data should be three: the promoter, the switch 109 
and the reporter. 110 
 111 
The promoter By enabling the tracking of cells and their progeny at any time point, lineage tracing is 112 
nowadays the most reliable technique to determine the stem or progenitor nature of a cell. However, the 113 
choice of the promoter is an essential determinant of results. For example, using lineage tracing Humphreys 114 
et alproved that tubular regeneration after acute kidney injury is totally derived from intrinsic epithelial 115 
cells.10 Indeed, in this elegant study, the authors employed a mouse line in which the Six2 promoter directly 116 
derived the expression of the Cre recombinase fused to the GFP.10 By crossing it with a Rosa26-LacZ or RFP 117 
reporter line they obtained the reporter heritable expression.10 The author were thus able to tag only 118 
Six2+renal epithelial precursors, which are present in the metanephric mesenchyme (MM) during the 119 
developmental period of active nephrogenesis.11 All the MM-derived nephron epithelial cells including 120 
tubular cells, but no extra-tubular cells, were thus marked.10 The paper demonstrated that, following an 121 
ischemic injury, no dilution of reporter-marked cells was present, and that surviving tubular cells were 122 
positive for both the reporter and the proliferation marker Ki67, indicating that all reparative epithelial cells 123 
originated from within the MM-derived nephron.10,18 The use of this promoter for tracing, however, does not 124 
discriminate between terminally differentiated epithelial cells and putative intra-tubular progenitors, since 125 
cells from which tubular structures of the nephron are derived are marked at the time of embryogenesis. In 126 
addition, the use of a constitutive system cannot completely exclude upregulation of the label within the 127 
tubules after development (as discussed in detail below). Thus, to finally dissect the contribution of potential 128 
intratubular progenitors to tubular regeneration, lineage tracing strategies based on other promoters were 129 
proposed. Indeed, Kusaba et al.19 used the sodium dependent inorganic phosphate transporter, SLC34a1, as a 130 
marker to trace terminally differentiated proximal tubular cells. Based on the fact that there is no dilution of 131 
fate marker after injury and repair, the authors concluded that progenitors do not participate in tubular 132 
regeneration.19 However, this work which relies on lineage tracing of a cell population unified by a cell 133 
marker, does not take into consideration the possibility that intrinsic renal progenitors may express 134 
differentiated tubular markers to some degree. Indeed, expression of differentiation markers by tissue 135 
resident progenitors was reported in several organs.20-24  Thus, the choice of a tubule differentiation marker 136 
for the promoter may not allow excluding the existence of tubular-committed progenitors since they would 137 
be genetically tagged similarly to differentiated tubular cells. 138 
Interestingly , several studies have proposed the existence in adult human kidney of a putative population of 139 
tubular progenitors characterized by co-expression of surface markers CD133 and CD24. These cellscan co-140 
express tubular markers although at lower levels than other differentiated tubular cells and localize within the 141 
tubule, scattered among differentiated tubular cells.25-27To trace these putative tubular progenitors,Berger et 142 
al.28, used a conditional mouse originally designed to reproduce the expression pattern of the endogenous 143 
podocalyxin gene within podocytes.8 In this mouse, transgene expression was unexpectedly detected within 144 
parietal epithelial cells of the Bowman‟s capsule but not within podocytes.8 This allowed tracing the 145 
migration of parietal epithelial cells within the glomerular tuft and demonstrate that these cells can act as 146 
podocyte progenitors during kidney development8.In further studies, the same authors demonstrated that 147 
parietal epithelial cells represent a major constituents of sclerotic lesions in focal segmental 148 
glomerulosclerosis and,together with podocytes,29, in crescents30,31. In a more recent article, Berger et al. 149 
proposed that committed podocytes are recruited from Bowman‟s capsule even after birth, and that this 150 
represents a committed intrinsic “podocyte reserve”, which can be recruited to allow glomerular growth32 151 
and may be particularly active in human33.Interstingly, Sagrinati et al. had described a progenitor potential of 152 
parietal epithelial cells in human.,34-38Of note, in human, parietal epithelial cells of the Bowman‟s capsule 153 
appear as undifferentiated at the urinary pole38 and as podocyte-committed in more proximity to the vascular 154 
pole38 and, like  putative tubular progenitors, are characterized by co-expression of CD133 and CD24.34-38. In 155 
their study, Berger et al. assumed that, similarly to CD133, their mouse may tag tubular progenitors in 156 
addition to parietal epithelial cells and then described a lack of amplification of tagged tubular cells 157 
following acute kidney injury.28However, at difference with cells expressing CD133 in human kidney, that 158 
were previously reported to behave as progenitors in vitro and following their transplantation in models of 159 
acute tubular injury in vivo,26,34-41 the scattered tubular cells in the transgenic mouse described by Berger et 160 
al.were not functionally studied.28In this mouse, multiple different cell types in addition to parietal epithelial 161 
cells are tagged, and the progenitor nature of the tagged scattered tubular cells is hypothesized based on 162 
expression of four markers that are shared by CD133+ human renal cells as well as by mouse parietal 163 
epithelial cells of the Bowman‟s capsule in addition to other cell types. Of note, the distribution of tagged 164 
tubular cells is also different from that reported for the CD133+ human tubular progenitors, that are mostly 165 
localized in the S3 segment and distal tubule,26,34 while tagged cells in this mouse mostly localize in the 166 
S1+S2, as well as S3 segment.28. Since it is unknown if tubular progenitors in this mouse are really tagged, 167 
the absence of their amplification in response to injury does not allow to conclude about their existence and 168 
role. Thus, as a general concept, if lineage tracing strategies demonstrate self renewal and differentiation 169 
capacity of the tagged cell population, one can conclude positively on the existence of a progenitor 170 
population. However, if the cell type marked by the promoter is unknown, negative results never allow 171 
definitive conclusions. Thus, the questions if tubular progenitors exist in the mouse and are involved in 172 
tubular regeneration remain open. This further underlines how critical is the choice of the promoter used for 173 
lineage tracing. For all these reasons, to draw conclusions about putative tubular progenitors, models that 174 
exploit physiologically expressed genes at single cell resolutions that are progenitor-specific and which, 175 
consequently, may unify human and mouse studies, are mandatory. 176 
In fact, human stem cell studies usually rely on prospective isolation based on specific markers followed by 177 
functional analysis including in vivo transplantation assays).34-41Accordingly, in the human fetal kidney and 178 
Wilms tumor, Ncam1 and Aldh1 (especially the Aldh1a2 paralogue),42-47 CD133 and CD2448 have been put 179 
forward as stem/progenitor cell markers in early mesenchyme (Six2
+
) and derived epithelial precursors (Six2
-180 
).42-48In the human adult kidney, CD133, CD24 and Aldh have been suggested to mark putativein situ 181 
epithelial progenitor populations while Ncam1 down-regulated after completion of nephrogenesis and 182 
reactivated in culture and following injury,49delineated aclonogenic cell subset that exhibited de-183 
differentiation, epithelial-to-mesenchymal transition characteristics converting  to a stem cell-like state.49 184 
Lineage tracing based on such markers may define a role in tubular homeostasis and regeneration for 185 
progenitors similar to the ones described in human. A prerequisite for this analysis is that a given 186 
marker/promoter would share homology in humans and mice, similar mRNA or protein levels and similar 187 
expression domain. This could be relevant to Ncam1/Aldh1a2 and hence generation of conditional 188 
Ncam1/Aldh1a2-CreERT2 mice would clarify a role in development and in adults. In contrast, markers such 189 
as human CD133 cannot be used in the mouse kidney.50 Indeed, human CD133 was first isolated from 190 
hematopoietic stem cells by a monoclonal antibody recognizing a specific epitope designated as AC133.51,52 191 
Once included in the Cluster of Differentiation nomenclature (CD), it was thus classified based on the name 192 
of the epitope (CD133).51,52  CD133 currently serves as a useful marker for the isolation of many different 193 
types of stem and progenitor cells in adult human tissues, even for clinical purpose.51,52 However, antibodies 194 
that recognize portions of the human CD133 protein different from the AC133 epitope do not specifically 195 
recognize stem cells, but are rather expressed by many differentiated epithelia.51,52 Recent results suggest that 196 
only antibodies that recognize epitopes localize in the second extracellular loop, like the AC133 and 293C3 197 
clones used to identify human renal progenitors,50 are suitable for stem cell and progenitors recognition.51,52 198 
Although for these reasons use of CD133 mRNA or gene to detect renal progenitors in the mouse is currently 199 
not possible,34,50a lineage tracing approach that uses a promoter that is co-expressed with CD133 on renal 200 
progenitors may be suitable. Future studies are required to address this possibility. Importantly, there may 201 
exist the opposite situation in which a murine marker such as Sca1, previously shown to identify an MSC-202 
like cell population in the adult mouse kidney),49 has no homologous protein in humans, precluding 203 
transplantation assays with counterpart human cells. Therefore, for any kind of promoter system used, the 204 
expression pattern has to be accurately chosen and verified prior to the actual cell fate tracing experiments. 205 
 206 
The switch The power and specificity of lineage tracing is in the variety of 'switches' that are now available 207 
to allow a temporal control over the activity of the Crerecombinase. Indeed, it must be underlined that the 208 
simple use of a cell-specific promoter that directly drives Cre expression without the use of a switch that 209 
allows turning on and off of Crerecombinasetranscription over time, can alter the results obtained with 210 
lineage tracing. Indeed, transient expression of the gene in another cell population, or later expression in cells 211 
of the tissue under study can induce de novo activation of Cre recombinase in a way that a part of the newly 212 
generated cells won‟t be derived from initially tagged ones. This in vivo genetic fate mapping is frequently 213 
confused with lineage tracing analysis and cannot give conclusive results, and often leads to over 214 
interpretation of the data. For example, Sakamoto et al.53 concluded, in a model of FSGS, that podocytes 215 
transit into a parietal epithelial cell phenotype53. However, in the constitutive mouse model used in this 216 
study, upregulation of podocyte markers may have occurred in whatever moment in parietal epithelial cells 217 
leading to Crerecombinase activation and cell tagging, and thus the labelled cells may also represent parietal 218 
epithelial cells differentiating into podocytes.53 For this reason, lineage tracing needs to be based on temporal 219 
regulation of marker gene expression. To this aim,inducible models have been created, also termed 220 
conditional models. Cell-specific promoters have been modified with regulatory elements that control Cre 221 
expression only when activated by specific exogenous molecules. As a consequence, the Cre recombinase 222 
will recombine the DNA in the desired cells that express the marker gene, only during the administration of 223 
the inductor molecule, thus opening a transient window in which cells may be labeled. Upon withdrawal of 224 
the molecule, no other cell that has not been labeled during the administration window can undergo genetic 225 
recombination, neither if it express the cell-specific promoter. Conditional assays principally rely on 226 
Tamoxifen-regulated systems (CreERT) (Fig. 1A) or on Tetracycline-regulated systems (Fig. 1B). 227 
Tamoxifen-based systems are built to constitutively express an inactivated form of Crerecombinase fused to 228 
a modified Estrogen Receptor (ERT) (Fig. 1A). When tamoxifen binds to the ER the protein can modify its 229 
structure and enter the nucleus, gaining access to DNA, where activated Cre may recombine (Fig. 1A). In 230 
Tetracycline-controlled systems the cell-specific promoter drives the expression of a reverse tetracycline-231 
controlled transactivator (rtTA) (Fig. 1B). When this protein is ligated by administered Doxycycline, it will 232 
bind DNA sequences of Tetracycline-controlled transcriptional activation-elements (Tet), which in turn 233 
drives Cre expression (Fig. 1B). Cre will than act on the reporter transgene by ligating loxP elements (Fig. 234 
1B). An interesting comparison of how different the result can be when obtained with constitutive versus 235 
conditional mice can be observed in two recent studies by Pippin et al., who used the renin gene as a cell-236 
specific promoter in order to label and trace cells of the juxtaglomerular apparatus.54,55 The authors 237 
demonstrated that renin expressing cells have regenerative capacity and are able to replace podocytes as well 238 
as parietal epithelial cells in a mouse model of FSGS, suggesting that they may serve as upstream 239 
mesenchymal progenitors for both parietal epithelial cells and podocytes.54 In both of these studies, the 240 
authors used a constitutive model in which renin drives the recombination that leads to fluorophoreZsGreen 241 
expression, within cells.54,55Using this fate mapping approach, the authors reported an increase in cells of 242 
renin lineage in the intraglomerular compartment at 14 days after injury, with a subset that coexpressed the 243 
podocyte markers nephrin, podocin and synaptopodin, indicative of a podocyte-like marker 244 
phenotype.54Since any cell population that had expressed renin, in any moment of animal life, would result 245 
as genetically tagged, the use of a constitutive model here, limites our interpretations into whether the renin-246 
positive population contributes to podocyte replenishment. Moreover podocytes can express renin under 247 
some circumstances, which could be an alternative explanation for for the co-expressions of podocyte 248 
markers and fluorescence signal.56-58 In one of the two studies54 the authors also used a conditional mouse 249 
system to perform lineage tracing of renin cells, and similarly concluded that these cells can act as podocyte 250 
progenitors.54However, when traced with the conditional mouse in the same FSGS model, renin expressing 251 
cells that derived from podocytes appeared to be extremely rare, more than ten fold less than with the 252 
conditional mouse.54,55These studies reveal that these methodological aspects can have strong impact on data 253 
interpretation and conceptual conclusions.  254 
Interestingly, a recent study by Starke et al 9further analyzed the hypothesis that cells of renin lineage act as 255 
precursors for other renal cells by using an inducible mouse model that labeled renin cells with β-gal. 9 In 256 
that paper, the authors demonstrated that two-thirds of the glomerular tufts became β-gal positive following 257 
mesangial injury and intraglomerular renin descendant cells colocalized only with mesangial but not with 258 
endothelial, podocyte, or parietal epithelial cell markers, suggesting that renin cells can act as precursors for 259 
mesangial cells, but not for podocytes.9 Thus, further studies are required to effectively address the 260 
contribution of renin cells to podocyte replenishments.  261 
Although the use of a time dependent switch is an essential pre-requisite for a correct lineage tracing 262 
experiment, further important caveats should be considered when designing such an experiment and 263 
interpreting results. First of all, it has to be considered that the doses of the drug given to the animal will 264 
affect the analysis, and thus must be chosen depending on the experimental purpose. Indeed, low or sub-265 
optimal administration will label the population of interest at clonal density, and it is therefore used to study 266 
origins of particular cell population, as demonstrated by Rios et al.3 High doses will instead maximize the 267 
labeling of the entire stem/progenitor pool, enabling the visualization of their cumulative contributions 268 
within the entire compartment.13,14 Second, an important limitation for conditional experiments can be 269 
leakiness of the system: where there is residual recombination even in the absence of induction. Because of 270 
this limitation, multiple control groups must be estimated in all experimental conditions, and various tissues 271 
must be evaluated. Additional limitations include, transgene constructs that may spontaneously silence and 272 
lead to under representation of data.Cell fusion events may also occur in vivo in a number of tissues59leading 273 
to spreading of fluorophore expression, and to false interpretations of multi-lineage contributions.13,14,60Third, 274 
it must be considered that drugs like tamoxifen or doxycycline can be given through different routes of 275 
administration, like intraperitoneally, by chow or drinking water, introducing a variability in results, 276 
depending on timing, health conditions, age, weight, and more. Finally, mosaic activation of cre 277 
recombination can occur. Indeed, ideally, the reporter gene is driven by a ubiquitously active promoter or 278 
gene locus. Unfortunately, no such promoter has been identified so far. Viral promoter fragments usually are 279 
transcriptionally active in a mosaic fashion, and the ROSA26 locus is transcriptionally active at a low level 280 
in most cells but it may be transiently down-regulated in diseased tissue." 281 
All these considerations, highlight how challenging lineage tracing experiments can be, and how an accurate 282 
choice of the switch and of its timing, are critical determinants of the results and of their interpretations. 283 
 284 
The reporter The third critical ingredient for a lineage tracing experiment is the choice of the reporter. 285 
Traditionally, the Escherichia coli lacZ gene, β-galactosidase, was one of the first reporters used for lineage 286 
tracing and has been used extensively.13,14β-galactosidase produces an intense blue color when incubated 287 
with the substrate analog X-gal, but is technically difficult and can be variable. Alternatively, beta-gal can be 288 
visualized using immunofluorescent stainings, although with such methods podocytes may show low-level 289 
background staining.13-15 Fluorescent reporters have become the new standard, and in this case detection by 290 
epifluorescence is far superior to antibody-enhanced methods, which are subject to nonspecific binding of 291 
antibodies and also raises the possibility of imaging clones of cells in living tissue through the use of 292 
multicolor reporters. Such dynamic analysis of cell-fate decisions is facilitated by advances in imaging, such 293 
as two- or multiphoton fluorescence microscopes, which enable in-depth scanning and optimal fluorophore 294 
separation of the multicolor fluorescence, as recently illustrated by an elegant study that used this approach 295 
to visualize podocyte response to injury.61 In multicolor reporters, attention should be paid to the use of lines 296 
that express Cre constitutively because a change in cell color (“flipping”) may occurs even after the initial 297 
Cre recombination. Therefore, multicolor reporters are optimal when used in combination with inducible Cre 298 
models. The high choice of different reporters that are becoming available is now one of the major strengths 299 
of lineage tracing approaches, but can also limit comparisons of results and their interpretations. For 300 
instance, the sensitivity to Cre-mediated recombination of different reporter alleles targeted to the Rosa26 301 
locus can vary substantially. Some Rosa26-targeted reporters will respond efficiently to Cre but can show 302 
leaky expression (background expression) in the absence of the Cre-inducing drug.13-15 Others are less 303 
efficient, and so have less background.13-15These issues are crucial when comparing studies in which Cre is 304 
being used to report gene expression or signaling activity, as the proportion of cells labeled may reflect the 305 
reporter that is used as much as the level of Cre activity.13-15 However, a careful choice of the reporter may 306 
even allow sophisticated quantitation of regeneration after injury processes. To this aim, one of the most 307 
used reporter genes is the mT/mG(membraneTomato/membraneGreen) transgene, which is characterized by 308 
a constitutive expression of the membrane bound fluorescent Tomato Red protein in all the cells of the 309 
animal body (Fig. 2A). As the sequence encoding the Tomato Red is floxed by two loxP site, only cells that 310 
will undergo recombination events will be able to express the membrane bound GFP which is downstream of 311 
Tomato Red, thus turning red into green (Fig. 2A). One example of a paper which used this system is 312 
Wanner et al.that studied podocyte turnover and regeneration in aging, in a unilateral nephrectomy models 313 
and following acute podocyte loss.62 To study severe podocytes depletion the authors employed a quadruple 314 
transgenic model in which the podocyte marker Podocin conditionally induced the shift of the mT/mG 315 
transgene present on one Rosa26 allele, while inducing the expression of the human simian Diphtheria toxin 316 
receptor (iDTR) transgene, codified under the other Rosa26 allele (Fig.2).62 Using this 317 
methodology,podocytes were tagged in green and were induced to express the iDTR following doxycycline 318 
administration, making them susceptible to a specific ablation as a consequence of the Diphtheria toxin 319 
injection.62 With this approach, newly generated podocytes can only be red colored due to the withdrawal of 320 
doxycycline before the onset of the damage.62While this approach enables quantification of de novo 321 
generated podocytes, it does not permit to identify the source of the novel podocytes population, neither does 322 
it allow to establish the origins or identities of the progenitor population.62 By employing this transgenic 323 
mouse model the authors reported, at 4 week from Diphtheria toxin (DTA) injection, a significant increase in 324 
the percentage of red-positive (newly generated) podocytes after ablation (Fig. 2B), corresponding to 325 
regeneration of 38% of lost podocytes, while after nephrectomy and in an aging model no increase in 326 
Tomato Red+podocytes was reported.62Interstingly, the DTA model is the only one that is characterized by 327 
podocyte depletion, while nephrectomy and aging do not necessarily lead to podocyte loss. This suggests that 328 
podocyte regeneration may occur only after podocyte detachment or death.  329 
Even if genetically modified mice with inducible recombination under different promoters have been used 330 
for in vivo fate mapping in the kidney, these analyses were performed on the population level, and not on 331 
individual cells. As such, cellular models for kidney development, physiologic tissue maintenance, and 332 
regeneration in vivo remained open questions. To this aim, multicolour reporters, that enable combinatorial 333 
expression of multiple fluorescent proteins in a stochastic manner under the control of a specific 334 
promoter,like the „Brainbow‟ (Fig. 3), „Rainbow‟or „Confetti‟ constructs, have opened a new wide range of 335 
possibilities. 336 
Rinkevich andDekel.,12 have recently utilized such a genetic marking strategy for lineage tracing of 337 
individual renal precursors in the adult mouse kidney. This strategy entails the use of a multicolor (red, 338 
yellow, green, blue) Cre-dependent reporter construct within the ROSA locus (R26VT2/GK3, termed 339 
„Rainbow‟), in addition to a lineage tracing strategy that is independent of candidate markers (using an 340 
inducible Cre-ER fusion protein under the ubiquitous Actin promoter). ActinCreER; R26VT2/GK3offspring 341 
injected with tamoxifen, induced cytoplasmic fusion protein to enter the nucleus and permanently recombine 342 
a random single color-encoding gene in all renal epithelial cells, regardless of their locations, marker gene 343 
expressions or developmental potentials.12 Using this unbiased assay, clonal analysis of individual cells over 344 
a 7-month period was performed, revealing the emergences of unipotent clones of three major types 345 
(proximal, distal tubule, and collecting tubules) each of which contributed to individual tubule segments over 346 
that tracing period12 (Fig. 4A).Because of the cellular density of the kidney tissue, clonal analysis using a 4-347 
color reporter construct may mask cellular contributions from adjacent and similarly colored cells to these 348 
clones.12To circumvent this possibility, Rinkevich and Dekel., have employed a protocol using single and 349 
low doses of tamoxifen. In these experiments, the tissue frequency of recombination was low enough (<1%) 350 
as to sparsely label single cellswith individual fluorescent colors within large and non-colored kidney 351 
domains.12 These low-dose experiments demonstratedthat large and single colored clones are outputs of 352 
individual cells that generate and regenerate the kidney epithelia12 (Fig. 4B, white arrows). Thus, using a 353 
ubiquitous, unbiased promoter (Actin), clonal analysis helped identify a distinct mode of renal epithelial cell 354 
turnover in maintenance and following ischemia and toxic AKI.12 Long-term lineage tracing in vivo revealed 355 
significant tubulogenesis has occurred within the mature kidney epithelia that produce slowly expanding 356 
clonal foci with segmental boundaries. To visualize the full sizes and distributions of clones Rinkevich and 357 
Dekel isolated intact nephron segments from ActinCreER; R26VT2/GK3 mice that were chased for 7-months12 358 
(Fig. 4, C, D). Intact tubules exhibited large epithelial clones within individual segments indicating that cells 359 
with lineage-restricted capacities and progenitor characteristics reside within tubule segments of the 360 
nephron.12 Following this 7-month clonal analysis, large clones also appeared within multiple glomeruli (Fig. 361 
4, E-G), indicating that both adult tubules and glomeruli house active clone forming cells.12 362 
Another system that is employed for lineage tracing and clonal analysis during embryonic development 363 
involves the creation of multicolored chimeric mice, termed tetrachimera mice.63 These mice are generated 364 
by injecting mouse embryonic stem cells that express separate fluorescent proteins (GFP-mES, RFP-mES, 365 
CFP-mES) into wild-type blastocysts.63 Kidneys from generated tetrachimera mice revealed that mature 366 
nephrons were polyclonal,indicating derivation during development from mixed contributions of clones, 367 
each of which contributed to individual tubule segments and to individual regions within nephrons63 (Fig. 368 
4H).  369 
Clonal analysis can further be used in the context of generating renal organoids. Following our previous 370 
success in establishing long-term kidney sphere cultures from single cell suspensions of human patients, 371 
recapitulating renal features and in vivo renal capacity ,42,64Rinkevich et al.12recently used the Rainbow 372 
system to investigate the in vitro fates from individual renal precursors, by establishing a culture system of 373 
growing murine renal epithelial organoids in suspension.12 In this assay, kidneys were harvested from 374 
ActinCreER; R26VT2/GK3 mice immediately after a tamoxifen administration regimen, dissociated into single 375 
cells, and plated with matrigel. Within several days of culturing, monoclonal renal organoids developed from 376 
individual cells that gradually enlarged, and then opened into hollow spheres resembling renal tubes in 377 
vivo.12 Similar to in vivo observations, clonal progeny developing within renal organoids maintained segment 378 
identity. When combined with isolation of renal cell fractions using flow cytometry, This type of approach 379 
allows the identifications of in vitro clonal efficiencies as well as progenitor frequencies within isolated 380 
FACS-sorted renal fractions12 (Fig. 4, I-I’’).  381 
The same study also examined the clonal capacities of Wnt-responsive cells by using a Wnt reporter 382 
AxinCreERthat expresses the Cre-ER fusion protein under the promoter of the Axin gene; which provides 383 
negative feedback in the Wnt-β-catenin signaling pathway.Single cell analysis was performed on the 384 
population of renal cells that where Wnt responsive by crossing Axin2CreER mice to „Rainbow‟ reporter 385 
mice.12 Axin2CreER; R26VT2/GK3 that were lineage traced from e17.5 up to the 5th postnatal months showed 386 
single colored and large clones within the adult tubules, indicating that they derived from individual Wnt-387 
responsive precursors12 (Fig. 4J). The authors performed a comparison of clone size between the unbiased 388 
clonal analysis (ActinCreER promoter) and clonal analysis using Wnt-responsive cell fractions 389 
(AxinCreERpromoter).12 Their analysis suggests that Wnt-responsive cells (WRCs) are cells with significant 390 
proliferative capacity, behaving de factoas long-lived unipotent progenitors when an appropriate stimuli to 391 
clonally expand/self-renew is received.12 392 
Consistent with this, Barker et al7has identified cells within developing kidney (following epithelial 393 
induction)  that express LGR5+(a Wnt co-receptor).The authors crossed LGR5CreER with a similar multicolor 394 
(red, yellow, green, blue) Cre-dependent reporter construct within the ROSA locus (the Confetti reporter) 395 
and found individual LGR5+cells (most likely Wnt responsive cells) as the immediate progenitors that 396 
generate the thick ascending limb of Henle's loop and distal convoluted tubule.7Despite the fact that LGR5 is 397 
silenced at postnatal stagesof development and fails to trace Wnt-responsive cells in the adult, both reports 398 
demonstrates that constant tubulogenesis is occurring within the mammalian kidney via a similar mechanism 399 
involving Wnt-responsive precursors giving rise to other cells. 400 
Taken altogether, the in vivoclonal analysis demonstrates that lineage-committed cells with progenitor 401 
characteristics continuously maintain and self-preserve the mouse kidney throughout life and after AKI.  402 
 403 
An outlook on emergingmethodologies In the most recent years, novel techniques emerged that can 404 
potentially solve many of the ongoing questions and debates about kidney regeneration. The recent 405 
observation that adult progenitors expressing low levels of differentiation markers may be involved in 406 
regeneration of adult tissues was for example recently addressed in the brain by using Split-cre. Such a 407 
strategy, which can allow lineage tracing of a specific population in response to a combination of two 408 
reporters, can be achieved by expressing the two fragments of a split Cre recombinase from two different 409 
tissue-specific promoters.65,66 This lead to the characterization of different types of progenitors in adult 410 
mouse brain based on co-expression of CD133 and neural-specific markers.22-24,67Fate mapping experiments 411 
based on the overlapping activity of two promoters can also be performed by using two independent 412 
recombinases (Cre and Flp) driven by two promoters combined with a special reporter allele.67 This system 413 
has been used to identify and analyse neural progenitors in several brain regions.23,24,68 These strategies may 414 
be applied also to address the existence and potential role of renal progenitors in the mouse kidney.  415 
Although lineage tracing techniques hold the potential tochange our knowledge of kidney biology, they add 416 
to their complexity being time consuming and highly costly. Indeed, genetic manipulation in mammalian 417 
species are usually made in the germline of an organism, which can then be used to create a stable transgenic 418 
strain for experimentation.69 Recently, howver, the RNA-guided endonuclease Cas9 from microbial type II 419 
CRISPR (clustered regularly interspaced short palindromic repeat) systems (previously referred to as Cas5 or 420 
Csn1)70-78 has been harnessed to facilitate genetic manipulations in a variety of cell types and organisms 421 
(reviewed in Hsu et al., 2014).77 A major advantage in CRISPR/Cas gene editing is that reactions can be 422 
multiplexed to introduce multiple genome modifications in a single step.77,78Cas9 can be easily 423 
reprogrammed using RNA guides to generate targeted DNA double-strand breaks (DSBs), which can 424 
stimulate genome editing via one of the two DNA damage repair pathways: nonhomologous end-joining 425 
(NHEJ), resulting in insertions and deletions (indels) or homology-directed repair (HDR), resulting in precise 426 
sequence substitution in the presence of a repair template.77,78 Unlike other programmable nuclease systems 427 
used for genome editing, a unique advantage of the Cas9 system is that Cas9 can be combined with multiple 428 
single-guide RNAs (sgRNA). However, commonly used delivery systems based on lentiviral and adeno-429 
associated viral (AAV) vectors have limited packaging capacity which renders it challenging for 430 
incorporation of Cas9 along with sgRNA expression cassettes and necessary genetic elements (i.e., 431 
promoters, fluorescent proteins, and polyadenlyation sequences). Thus, to facilitate broader applications of 432 
CRISPR-Cas9, Platt et al. generated a Cre-dependent Rosa26 Cas9 knockin mouse to overcome the delivery 433 
challenges associated with Cas9 (Fig. 5).79Cas9-expressing cells derived from the constitutive Cas9-434 
expressing mice facilitate genomeediting because it requires only the introduction of sgRNAs, which can be 435 
efficiently delivered using viral and nonviralsgRNA delivery methods.79This mouse can be used in 436 
conjunction with a variety of guide RNA delivery reagents, including to facilitate genome editing in multiple 437 
tissues in vivo (Fig. 5). 79In vivo as well as ex vivo genome editing using adeno-associated virus (AAV)-, 438 
lentivirus-, or particle-mediated delivery of guide RNA in neurons, immune cells, and endothelial cells was 439 
reported.79 More importantly, Platt et al. delivered a single AAV vector in the Cre-dependent LSL-Cas9 440 
model to generate loss-of-function mutations in the tumor suppressors Trp53 (p53) and Lkb1, and homology-441 
directed repair modification of Kras to oncogenic KrasG12D simultaneously.79 Intra-tracheal delivery of this 442 
vector, which also carried Cre and a luciferase reporter sequence in addition to the sgRNA and KrasG12D 443 
homology repair templates, resulted in adenocarcinomas in 100% of the infected animals.79 These data 444 
suggest that the conditional LSL-Cas9 mice provide exciting new tools to perform targeted genomic 445 
manipulation in traditionally challenging cell types in vivo and ex vivo, and to generate novel and fast 446 
strategies for lineage tracing which hold great promises for regenerative studies.  447 
 448 
Conclusion 449 
Lineage tracing strategies are powerful tools that are now growingly applied to understand the physio-450 
pathological mechanisms that govern kidney regeneration and disease. Novel options to enhance the system 451 
and its possible applications are continuously becoming available, further increasing its possible 452 
applications. Caution must be paid particularly to the type of promoter, switch and reporter used, as well as 453 
on the induction times that are best to study the pre-specified end points. Even with these caveats, lineage 454 
tracing strategies are making accessible to our knowledge a wide range of processes, including kidney 455 
regeneration, which can now be directly visualized for the first time. Lineage tracing methods at single cell 456 
resolutions rather than cell populations would provide the most accurate genealogical descriptions of 457 
stem/progenitor behaviors. Consequently, novel types of murine models where renal progenitors are 458 
specifically tagged are being produced, and novel techniques to reduce the complexity and costs of lineage 459 
tracing experiments are appearing.Gradually,mechanisms of kidney regeneration are being clarified and new 460 
answers to old questions are gradually being found. These approaches and their use will allow the 461 
identifications and complete characterizing of all progenitor populations within the kidney and their 462 
contribution to kidney regeneration with unprecedented resolution and accuracy.  463 
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 651 
Figure 1 Cre-recombinase-based lineage tracing system. Schematic representation of two of the most 652 
common strategies used for lineage tracing. The genetic background of one animal is altered such that a 653 
specific promoter is used to induce Cre recombination in specific cells. These mice are crossed to a reporter 654 
animal harbouring a stop codon flanked by Cre-recombinogenicloxP sites upstream of a reporter gene, such 655 
as lacZ or GFP, under the control of the Rosa26 promoter. In mice expressing both genetic elements, Cre 656 
recombinase excises the stop codon, such that Rosa26 drives expression of the reporter in stem cells. Once 657 
marked in this way, all descendants propagate the expression of the reporter under Rosa26promoter control.  658 
In Cre recombinase expression can be activated at defined time-points through treatment with specific drugs. 659 
(A) Temporal restriction can be achieved by fusing the Cre recombinase gene to the tamoxifen-responsive 660 
hormone-binding domain of the estrogen receptor (Cre-ER
TAM
). The Cre enzyme is in an inactive state in the 661 
absence of the ligand tamoxifen. Once tamoxifen is added, the Cre is active and can translocate to the 662 
nucleus. In the absence of tamoxifen, no expression of the reporter gene is observed because of the presence 663 
of the stop signal upstream of the reporter gene. When tamoxifen is administered, the Cre is activated and 664 
mediates recombination between the loxP sites in cells. As a consequence, the STOP codon is excised and 665 
the cells are permanently marked by the reporter gene. ER, estrogen receptor; GFP, green fluorescent 666 
protein. (B) Tet-on strategy for inducible and temporal control of transgene expression is based on the 667 
tetracycline (tet) bacterial resistance gene operon. Three transgenic lines are required. The first transgenic 668 
line contains the tTA under the control of a cell-specific promoter: this line provides the selectivity to the 669 
system. The second transgenic line contains the transgene of interest under the control of the tet operon 670 
(TetO) DNA-binding element. The TetO promoter element can be activated upon binding of the tetracycline 671 
transactivator (tTA) to drive ubiquitous expression. The third transgenic line contains the reporter system. 672 
When a tetracycline derivative, such as doxycycline, is given to the trigenic mice (obtained from breeding 673 
the tTA line with the TetO line, and then with the reporter line) in the drinking water, doxycycline binds to 674 
tTA to induce its interaction with the TetO minimal promoter and thereby turns on transgene expression 675 
selectively in the desired cell type. 676 
 677 
Figure 2 mT/mG Cre-recombinase-mediated reporter for lineage tracing in the kidney.  678 
(A) mT/mG is a double-fluorescent Cre reporter construct that expresses membrane-targeted tandem dimer 679 
Tomato (mT) prior to Cre-mediated excision and membrane-targeted green fluorescent protein (mG) after 680 
excision. Tomato reporter expression is nearly ubiquitous, allowing visualization of fluorescent markers in 681 
live and fixed samples of all tissues examine, while mG labeling is Cre-dependent, complementary to mT at 682 
single cell resolution, and distinguishable by fluorescence-activated cell sorting. Both membrane-targeted 683 
markers outline cell morphology, highlight membrane structures, and permit visualization of fine cellular 684 
processes, and thus are ideal to study podocytes. (B) mT/mG image of an 685 
hNPHS2.rtTA;TetO.Cre;mT/mG;iDTR kidney previously induced with doxycycline, treated with DT as 686 
previously reported49and compared with healthy controls. After staining with synaptopodin (blue), this model 687 
allows visualization of resident podocytes (green and blue), and of de novo generated podocytes (red and 688 
blue) after podocyte injury. Left: A healthy glomerulus, where all resident podocytes appear as green and 689 
blue after doxycycline induction of Cre recombinase activation. Right: After doxycycline washout, induction 690 
of podocyte injury with iDTR treatment is followed after one month by generation of novel podocytes that 691 
are not derived from resident podocytes, as demonstrated by the lack of green signal. Newly generated 692 
podocytes appear as synaptopodin positive cells (blue) that are red labelled, showing they were generated 693 
from an external progenitor. 694 
 695 
Figure 3: MulticolourCre-recombinase-mediated reporter for lineage tracing and clonal analysis. 696 
(A) Schematic representation of the genetic strategy to mark cells with multiple fluorescent proteins. One 697 
animal harbours a transgene encoding a cell-specific promoter driving Cre recombinase expression. These 698 
mice are crossed to a reporter animal that, under the control of the ubiquitous Rosa26 promoter, harbour a 699 
neomycin resistance gene flanked by Cre-recombinogenicloxP sites, and multiple genes, in sense and 700 
antisense orientations, encoding the fluorescent proteins, GFP, RFP, YFP and CFP (green, red, yellow and 701 
cyan fluorescent protein, respectively) that are flanked by Cre-recombinogenicloxP and inversion sites. Cre 702 
recombinase stochastically excises and inverts at the loxP sites to generate the possible transgenes shown, 703 
and allow Rosa26 to drive expression of multiple combinations of fluorescent proteins in cells and their 704 
progeny.  705 
 706 
 707 
Figure 4. Clonal analysis of the renal epithelia.  708 
(A) Merged Rainbow image showing single colored clones within the adult kidney following a 7-month 709 
chase in ActinCreER; R26VT2/GK3 mice. (B) Merged DAPI and Rainbow image showing outcomes of clonal 710 
analysis following low dose tamoxifen administration. Large and separate single colored clones are visable 711 
within tubule segments. (C, D) Intact nephrons isolated fromkidneys of ActinCreER; R26VT2/GK3 mice  indicate 712 
that significant tubulogenesis has occured within adult nephrons. (E-G) Merged Rainbow images of 713 
glumeruli showing sinle colored clones. (H) Merged tetrachimera image of a developing kidney. A large red 714 
clone contributing to a nephron segment. (I-I’’) Merged images of monoclonal renal organoids following 715 
clonal analysis in-vitro. (J) A large single colored clone emerge from a Wnt-responsive precursor, as 716 
observed by clonal analysis in AxinCreER; R26VT2/GK3 mice.  717 
 718 
Figure 5 CRISP-based systems for lineage tracing. Generation of a CRISP-based mouse was recently 719 
achieved bsed on Rosa26-LSL-Cas9 knockin mice have a floxed-STOP cassette preventing expression of 720 
the downstream bicistronic sequences (Cas9 and EGFP). Although under control of a CAG promoter, 721 
widespread expression cas9 and EGFP is prevented by the STOP cassette. After exposure to Cre 722 
recombinase, expression of cas9 and EGFP is observed. Cas9 expression is tightly controlled in a Cre-723 
dependent manner, whereas gene editing via viral delivery of cas9 is burdened by packaging size 724 
limits.These Rosa26-LSL-Cas9 mice only require one to select a Cre recombinase driven by the promoter of 725 
their choosing and a specific single guide RNA (sgRNA) for generating single or multiple simultaneous 726 
mutationsediting because it requires only the introduction of sgRNAs, which can be efficiently delivered 727 
using lentiviral vectors. 728 
 729 
 730 





